suberoyl bis-hydroxamic acid has been researched along with Precursor B-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
suberoyl bis-hydroxamic acid: antineoplastic, Histone Deacetylase inhibitor
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma: A leukemia/lymphoma found predominately in children and adolescents and characterized by a high number of lymphoblasts and solid tumor lesions. Frequent sites involve LYMPH NODES, skin, and bones. It most commonly presents as leukemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shao, N | 1 |
| Ma, D | 1 |
| Wang, J | 1 |
| Lu, T | 1 |
| Guo, Y | 1 |
| Ji, C | 1 |
1 other study available for suberoyl bis-hydroxamic acid and Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Notch1 signaling is irresponsible to the anti-leukemic effect of HDACis in B-ALL Nalm-6 cells.
Topics: Acetylation; Apoptosis; B-Lymphocytes; Cell Division; Cell Line, Tumor; Chromatin Assembly and Disas | 2013 |